Genetic architecture of the F7 gene in a Spanish population: implication for mapping complex diseases and for functional assays

Clinical Genetics
Maria Sabater-LlealJosé Manuel Soria

Abstract

Delineating the genetic variability of loci coding for complex diseases helps to understand the individual variation in disease susceptibility and drug response. We present the allelic architecture of the F7 gene. This gene is the major determinant of FVII plasma levels, and these plasma levels constitute an important intermediate risk factor for cardiovascular disease. As part of the Genetic Analysis of Idiopathic Thrombophila Project, we completely re-sequenced the F7 locus (promoter, exons, introns, and 3'-untranslated region) in 40 unrelated individuals. We found 49 polymorphisms with only two amino acid changes suggesting that regulatory non-coding and intronic variants are responsible for the FVII variability. These results are important for mapping susceptibility alleles of complex diseases, because differences in pair-wise linkage disequilibrium patterns between DNA variants and haplotype frequency distributions may help to detect disease-associated alleles. In addition, we present the results of an in silico search that established genomic comparisons among different species. In conclusion, our study of the F7 DNA sequence variations is an example of a strategy for analyzing the genetic architecture of a quantitative t...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·B Osterud, S I Rapaport
May 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·F GreenS Humphries
Aug 25, 1991·Nucleic Acids Research·G MarchettiF Bernardi
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P J O'HaraM J Murray
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Jan 1, 1986·Cold Spring Harbor Symposia on Quantitative Biology·G L Long
Sep 29, 1995·The Journal of Biological Chemistry·D Erdmann, J Heim
Jan 19, 1996·The Journal of Biological Chemistry·E S PollakK A High
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·D GreenbergE W Davie
Sep 13, 1996·Science·N Risch, K Merikangas
Aug 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·R JunkerG Assmann
Nov 14, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·M P de MaatC Kluft
Dec 31, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·M HunaultK A Bauer
Apr 4, 2000·Circulation·J C SoutoJ Fontcuberta
Dec 4, 2001·Nature Genetics·Gonçalo R AbecasisLon R Cardon
Jun 11, 2003·American Journal of Human Genetics·Zhaoling MengMargaret G Ehm
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·J A CarewK A Bauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.